Pacira Beefs Up Non-Opioid Pain Management Via Flexion Acquisition

By: via Benzinga
Pacira BioSciences Inc(NASDAQ: PCRX) hasagreed to acquireFlexion Therapeutics Inc(NASDAQ: FLXN) for $8.50 per ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.